Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-21669355

RESUMO

Congenital factor V deficiency was first described by Owren in 1947.(1) It is thought to be transmitted by an autosomal recessive gene (q23-24)(2) found in 1 out of every 1 million population and usually with no gender or race correlation.(3) To date, ~150 cases have been reported in the world literature.(3) The description of rare case of this disease is justified, because they may add further information about the condition of the hemorrhagic tendency. The object of the present paper was to report the bleeding control for extraction of 4 wisdom teeth with congenital factor V deficiency hemophilia and review the literature.


Assuntos
Deficiência do Fator V/congênito , Dente Serotino/cirurgia , Extração Dentária/métodos , Adulto , Anestesia Dentária , Anestésicos Locais/administração & dosagem , Epinefrina/administração & dosagem , Fator V/análise , Humanos , Coeficiente Internacional Normatizado , Lidocaína/administração & dosagem , Masculino , Hemorragia Bucal/prevenção & controle , Tempo de Tromboplastina Parcial , Plasma , Tempo de Protrombina , Vasoconstritores/administração & dosagem
2.
Ann Biomed Eng ; 39(1): 26-34, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20614244

RESUMO

A robust method for inducing bone formation from cultured dental mesenchymal cells has not been established. In this study, a method for generating bone tissue in vivo from cultured human dental pulp- and periodontal ligament-derived cells (DPCs and PDLCs, respectively) was designed using exogenous bone morphogenetic protein 2 (BMP2). DPCs and PDLCs showed enhanced alkaline phosphatase (ALP) activity and calcified nodule formation in medium containing dexamethasone, ß-glycerophosphate, and ascorbic acid (osteogenic medium). However, the addition of recombinant human bone morphogenetic protein 2 (rhBMP2) to osteogenic medium remarkably increased ALP activity and in vitro calcification above the increases observed with osteogenic medium alone. rhBMP2 also significantly upregulated the expression of osteocalcin, osteopontin, and dentin matrix protein 1 mRNA in both cell types cultured in osteogenic medium. Finally, we detected prominent bone-like tissue formation in vivo when cells had been exposed to rhBMP2 in osteogenic medium. In contrast, treatments with osteogenic medium or rhBMP2 alone could not induce abundant mineralized tissue formation. We propose here that treatment with rhBMP2 in osteogenic medium can make dental mesenchymal tissues a highly useful source of cells for bone tissue engineering. In addition, both DPCs and PDLCs showed similar and remarkable osteo-inducibility.


Assuntos
Desenvolvimento Ósseo/fisiologia , Proteína Morfogenética Óssea 2/administração & dosagem , Polpa Dentária/citologia , Osteogênese/fisiologia , Ligamento Periodontal/citologia , Engenharia Tecidual/métodos , Desenvolvimento Ósseo/efeitos dos fármacos , Diferenciação Celular , Células Cultivadas , Técnicas de Cocultura , Polpa Dentária/efeitos dos fármacos , Polpa Dentária/fisiologia , Humanos , Osteogênese/genética , Ligamento Periodontal/efeitos dos fármacos , Ligamento Periodontal/fisiologia
3.
Int Dent J ; 57(4): 286-8, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17849689

RESUMO

Subcutaneous emphysema is one potential complication of dental procedures, although most cases of emphysema implicate operative procedure. We present a rare case of subcutaneous emphysema which arose due to using an air syringe to dry the gingiva in the lower jaw.


Assuntos
Instrumentos Odontológicos/efeitos adversos , Pescoço/patologia , Enfisema Subcutâneo/etiologia , Adulto , Ar , Bochecha/patologia , Feminino , Seguimentos , Humanos , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA